How it works
A dual GLP-1 and glucagon receptor agonist studied to combine appetite control, glucose signaling, and energy expenditure.

AGE VERIFICATION
CATALOG ITEM

Identifying details were hidden for privacy. The test results are shown as they appeared in the original report. For research use only.
A dual GLP-1 and glucagon receptor agonist studied to combine appetite control, glucose signaling, and energy expenditure.
Studied for obesity, overweight, type 2 diabetes, and metabolic fatty-liver disease.
Metabolic contexts including weight, glucose, liver fat, and energy markers.
A dual GLP-1 and glucagon agonist, adding an energy-expenditure component.